vs
Dominari Holdings Inc.（DOMH）与ENANTA PHARMACEUTICALS INC（ENTA）财务数据对比。点击上方公司名可切换其他公司
Dominari Holdings Inc.的季度营收约是ENANTA PHARMACEUTICALS INC的1.6倍（$30.1M vs $18.6M），ENANTA PHARMACEUTICALS INC净利率更高（-64.1% vs -438.1%，领先374.0%），Dominari Holdings Inc.同比增速更快（220.4% vs 9.8%），过去两年Dominari Holdings Inc.的营收复合增速更高（369.1% vs 4.5%）
Enanta制药是一家临床阶段生物技术企业，专注于研发针对乙型肝炎病毒、呼吸道合胞病毒、新冠病毒等传染性疾病的创新抗病毒疗法，与全球制药伙伴合作推进小分子候选药物管线，满足未被覆盖的临床需求。
DOMH vs ENTA — 直观对比
营收规模更大
DOMH
是对方的1.6倍
$18.6M
营收增速更快
DOMH
高出210.6%
9.8%
净利率更高
ENTA
高出374.0%
-438.1%
两年增速更快
DOMH
近两年复合增速
4.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $30.1M | $18.6M |
| 净利润 | $-131.8M | $-11.9M |
| 毛利率 | — | — |
| 营业利润率 | -8.9% | -60.5% |
| 净利率 | -438.1% | -64.1% |
| 营收同比 | 220.4% | 9.8% |
| 净利润同比 | -12426.2% | 46.4% |
| 每股收益（稀释后） | $-6.94 | $-0.42 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOMHENTA
| Q4 25 | $30.1M | $18.6M | ||
| Q3 25 | $50.8M | $15.1M | ||
| Q2 25 | $34.1M | $18.3M | ||
| Q1 25 | $8.1M | $14.9M | ||
| Q4 24 | $9.4M | $17.0M | ||
| Q3 24 | $4.0M | $14.6M | ||
| Q2 24 | $6.2M | $18.0M | ||
| Q1 24 | $1.4M | $17.1M |
净利润DOMHENTA
| Q4 25 | $-131.8M | $-11.9M | ||
| Q3 25 | $125.2M | $-18.7M | ||
| Q2 25 | $16.6M | $-18.3M | ||
| Q1 25 | $-32.5M | $-22.6M | ||
| Q4 24 | $1.1M | $-22.3M | ||
| Q3 24 | $-4.2M | $-28.8M | ||
| Q2 24 | $-6.1M | $-22.7M | ||
| Q1 24 | $-5.4M | $-31.2M |
营业利润率DOMHENTA
| Q4 25 | -8.9% | -60.5% | ||
| Q3 25 | -3.1% | -121.6% | ||
| Q2 25 | -57.0% | -103.2% | ||
| Q1 25 | -394.6% | -164.3% | ||
| Q4 24 | 0.4% | -138.8% | ||
| Q3 24 | -79.1% | -204.4% | ||
| Q2 24 | -44.3% | -134.6% | ||
| Q1 24 | -205.2% | -192.1% |
净利率DOMHENTA
| Q4 25 | -438.1% | -64.1% | ||
| Q3 25 | 246.4% | -123.6% | ||
| Q2 25 | 48.7% | -99.7% | ||
| Q1 25 | -400.5% | -151.7% | ||
| Q4 24 | 11.4% | -131.4% | ||
| Q3 24 | -104.2% | -197.3% | ||
| Q2 24 | -99.1% | -126.1% | ||
| Q1 24 | -398.0% | -182.7% |
每股收益（稀释后）DOMHENTA
| Q4 25 | $-6.94 | $-0.42 | ||
| Q3 25 | $7.27 | $-0.88 | ||
| Q2 25 | $1.12 | $-0.85 | ||
| Q1 25 | $-3.02 | $-1.06 | ||
| Q4 24 | $0.21 | $-1.05 | ||
| Q3 24 | $-0.67 | $-1.36 | ||
| Q2 24 | $-1.01 | $-1.07 | ||
| Q1 24 | $-0.91 | $-1.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.5M | $37.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $69.4M | $126.6M |
| 总资产 | $112.9M | $329.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOMHENTA
| Q4 25 | $80.5M | $37.4M | ||
| Q3 25 | $176.2M | $32.3M | ||
| Q2 25 | $28.2M | $44.8M | ||
| Q1 25 | $18.9M | $60.2M | ||
| Q4 24 | $8.2M | $84.3M | ||
| Q3 24 | $7.2M | $37.2M | ||
| Q2 24 | $12.1M | $35.8M | ||
| Q1 24 | $7.1M | $63.5M |
股东权益DOMHENTA
| Q4 25 | $69.4M | $126.6M | ||
| Q3 25 | $210.2M | $64.7M | ||
| Q2 25 | $88.6M | $79.3M | ||
| Q1 25 | $42.4M | $93.5M | ||
| Q4 24 | $39.9M | $111.8M | ||
| Q3 24 | $38.3M | $128.8M | ||
| Q2 24 | $42.4M | $148.9M | ||
| Q1 24 | $47.7M | $166.1M |
总资产DOMHENTA
| Q4 25 | $112.9M | $329.5M | ||
| Q3 25 | $223.4M | $280.7M | ||
| Q2 25 | $109.3M | $301.0M | ||
| Q1 25 | $52.3M | $323.0M | ||
| Q4 24 | $47.1M | $348.6M | ||
| Q3 24 | $43.4M | $376.7M | ||
| Q2 24 | $49.1M | $398.8M | ||
| Q1 24 | $52.2M | $413.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.7M | $-11.7M |
| 自由现金流经营现金流 - 资本支出 | — | $-11.8M |
| 自由现金流率自由现金流/营收 | — | -63.6% |
| 资本支出强度资本支出/营收 | — | 0.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-18.5M |
8季度趋势，按日历期对齐
经营现金流DOMHENTA
| Q4 25 | $22.7M | $-11.7M | ||
| Q3 25 | $-4.9M | $-6.5M | ||
| Q2 25 | $-353.0K | $17.5M | ||
| Q1 25 | $1.2M | $-13.5M | ||
| Q4 24 | $-16.7M | $-16.8M | ||
| Q3 24 | $-4.7M | $-10.4M | ||
| Q2 24 | $1.4M | $-14.8M | ||
| Q1 24 | $-8.6M | $-28.6M |
自由现金流DOMHENTA
| Q4 25 | — | $-11.8M | ||
| Q3 25 | — | $-7.9M | ||
| Q2 25 | — | $17.4M | ||
| Q1 25 | — | $-16.0M | ||
| Q4 24 | — | $-25.5M | ||
| Q3 24 | — | $-19.4M | ||
| Q2 24 | — | $-21.3M | ||
| Q1 24 | — | $-30.3M |
自由现金流率DOMHENTA
| Q4 25 | — | -63.6% | ||
| Q3 25 | — | -52.5% | ||
| Q2 25 | — | 94.7% | ||
| Q1 25 | — | -107.4% | ||
| Q4 24 | — | -150.6% | ||
| Q3 24 | — | -132.5% | ||
| Q2 24 | — | -118.6% | ||
| Q1 24 | — | -177.5% |
资本支出强度DOMHENTA
| Q4 25 | — | 0.8% | ||
| Q3 25 | — | 9.6% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | — | 51.6% | ||
| Q3 24 | — | 61.3% | ||
| Q2 24 | — | 36.4% | ||
| Q1 24 | — | 9.8% |
现金转化率DOMHENTA
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
ENTA
暂无分部数据
